Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2. [electronic resource]
Producer: 20080228Description: 863-9 p. digitalISSN:- 1527-7755
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- blood
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- blood
- Disease Progression
- Disease-Free Survival
- Drug Administration Schedule
- Erlotinib Hydrochloride
- Female
- Humans
- Karnofsky Performance Status
- Lung Neoplasms -- blood
- Male
- Paclitaxel -- administration & dosage
- Protein Kinase Inhibitors -- administration & dosage
- Quality of Life
- Quinazolines -- administration & dosage
- Surveys and Questionnaires
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.